LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea

LivaNova PLC (NASDAQ:LIVN) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, LivaNova PLC (NASDAQ:LIVN) announced that the FDA granted premarket approval for its aura6000 System for treating adults with moderate to severe obstructive sleep apnea. The system uses proximal hypoglossal nerve stimulation to address patients with an apnea-hypopnea index of 15 to 65 who are unable to use or do not respond to first-line therapies such as positive airway pressure. Last month, B ...